20160128 EGA Regulatory and Scientific Affairs Conferenc

All routes to healthcare efficiency include biosimilar medicines

9 December 2020

Read More

EU Pharma Strategy: Success depends on access to Generic, Biosimilar and Value Added Medicines

25 November 2020

Read More

IGBA Launches First Global Biosimilars Week

16 November 2020

Read More

European Health Union – first step to greater EU solidarity in health crisis situations

11 November 2020

Read More

Joint EU-UK pharmaceutical industry response to Specialised Committee outcome

9 November 2020


Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines

5 November 2020

Read More

Open letter from Medicines for Europe Executive on the upcoming EU pharmaceutical strategy

20 October 2020

Read More

Statement from the President: Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing

7 October 2020

Berlin, 07 October 2020, speaking at ‘For a Healthy Europe’, […]

Read more

IGBA: Global Roadmap for Tailored Clinical Biosimilar Development: Instrumental for Sustainable Access to Biologics

24 September 2020


Joint press statement of European Pharmaceutical industry associations

17 September 2020


Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]